Female to Male of gender identity disorders
Conditions
Interventions
Intramuscular injection of testosterone
Sponsors
Department of Urology, Nagoya University Graduate School of Medicine
Department of Urologic Surgery and Andrology, Sapporo Medical University School of Medicine Department of Urology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: Female to Male patient without the previous hormone therapy
Exclusion criteria
Exclusion criteria: The patient who cannot accept inspection. The pregnancy or the patient who may be pregnant. The patient with the previous hormone therapy. The patient cannot contact continuously. The patient is not gender identity disorders and have possibility of serious diseases to adversely affect with hormone therapy. The patient who performed a sex reassignment surgery or the planned patient who perform a sex reassignment surgery in a study. The patient who is excluded to hormone therapy in "the guidelines on diagnosis and treatment third edition about gender identity disorders."
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Volume of esidual urine, Urination frequency, IPSS score, IPSS-QOL score, OABSS score | — |
Secondary
| Measure | Time frame |
|---|---|
| period to cessation of menses | — |
Countries
Japan
Contacts
Public ContactKazuna Matsuo
Nagoya University Graduate School of Medicine Urology
Outcome results
None listed